Clinical Trial Update: Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib with IMRT for inoperable or iodine-refractory thyroid cancer. Status not specified in available snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Xiayun He, MD | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN